<div id="readability-page-1"><p>Geode Capital Management LLC lifted its stake in shares of  Oscar Health, Inc. (NYSE:OSCR - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,798,313 shares of the company's stock after purchasing an additional 116,430 shares during the period. Geode Capital Management LLC owned 1.81% of Oscar Health worth $68,964,000 as of its most recent SEC filing.</p><ul><li>5 Small Cap Stocks With Explosive Upside Potential</li></ul><p>Several other institutional investors and hedge funds have also made changes to their positions in OSCR. American Century Companies Inc. boosted its holdings in shares of  Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after purchasing an additional 2,495,691 shares during the last quarter.  Farallon Capital Management LLC boosted its holdings in shares of  Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the last quarter.  Thrive Capital Management LLC raised its position in shares of  Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after buying an additional 1,588,395 shares during the period.  Marshall Wace LLP raised its position in shares of  Oscar Health by 3,796.6% during the 3rd quarter. Marshall Wace LLP now owns 1,137,839 shares of the company's stock valued at $21,539,000 after buying an additional 1,108,638 shares during the period.  Finally, Fred Alger Management LLC raised its position in shares of  Oscar Health by 225.6% during the 3rd quarter. Fred Alger Management LLC now owns 1,212,383 shares of the company's stock valued at $22,950,000 after buying an additional 840,038 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Oscar Health Stock Performance</h2><p>NYSE:OSCR opened at $27.37 on Tuesday. The company has a fifty day simple moving average of $18.70 and a two-hundred day simple moving average of $16.16. The company has a market cap of $8.25 billion, a price-to-earnings ratio of -46.39, a price-to-earnings-growth ratio of 1.71 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $27.59. </p><p>Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company's quarterly revenue was up 52.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 earnings per share.  As a group, equities analysts anticipate that  Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several research firms have recently commented on OSCR. Zacks Research raised shares of Oscar Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Thursday, May 7th. Raymond James Financial raised shares of Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 price target on the stock in a research report on Thursday, February 12th. Wall Street Zen lowered shares of Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday. Wells Fargo &amp; Company  set a $20.00 price target on shares of Oscar Health and gave the company an &#34;equal weight&#34; rating in a research report on Thursday. Finally, UBS Group lifted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, May 7th. One investment analyst  has rated the stock with a Strong Buy rating, two have issued  a Buy rating, eight have assigned  a Hold rating and one  has given a Sell rating to the company. According to data from MarketBeat, the stock  has an average rating of &#34;Hold&#34; and a consensus target price of $20.22.</p><p><b>Check Out Our Latest Stock Report on OSCR</b></p><h2>Insiders Place Their Bets</h2><p>In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of the business's stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $748,592.80. Following the completion of the transaction, the director owned 480,866 shares of the company's stock, valued at approximately $10,550,200.04. This trade represents a 6.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock valued at $4,283,140. Corporate insiders own  25.11% of the company's stock. </p><h2>Oscar Health Company Profile</h2> (Free Report)<p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.  </p><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Oscar Health</li><li>3 Stocks With Fresh Catalysts to Watch Before the July 4</li><li>Amprius Insiders Are Selling: Should Investors Be Worried?</li><li>A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus</li><li>A Market Rotation Toward Quality Will Benefit These 3 ETFs</li></ul><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2><p>Before you consider Oscar Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OSCR

OSCG

OSCX

<p>Geode Capital Management LLC increased its stake in Oscar Health (NYSE:OSCR) by 2.5% in Q4, holding 4.8 million shares valued at $68.96 million. Other institutions like American Century and Farallon Capital also boosted holdings. Oscar Health recently reported Q1 EPS of $2.07, beating estimates, with revenue of $4.65 billion. Analysts have mixed ratings, averaging 'Hold' with a consensus price target of $20.22.</p>

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

Raymond James Financial

Wells Fargo

UBS Group AG

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Oscar Health, Inc. $OSCR Shares Acquired by Geode Capital Management LLC